Aethlon Medical Inc (AEMD)

[ANESRI]

The fundamentals certainly do not look good. However my perspective is that this is a game changing technology from several fronts :

HCV - AEMD is planning studies with Fresenius. This can be a win win for both. Can be a huge revenue booster for F as they already are dealing with a lot of people with HCV. They have the infrastructure in place to get this going if it works out.
I feel that health care companies, insurance companies and the govt.(remember that the HP is already validated by DARPA) may take interest in this if they are made to realize the potential in terms of savings. HP as an adjunct to anti-HCV meds would decrease the total cost and hopefully give better long term results.

Sepsis - As we know this seems to be a multi - billion dollar market with no real cure in sight. The fact that AEMD was chosen by DARPA, and we are working with Batelle speaks a lot for HP.

It is amazing for a penny stock company to be partnering with some of the leading institutions around (I forgot about possible studies regarding exosomes with M.D. Anderson in Texas!).

There are other applications for the HP, which may add to the bottom line if any of the above take off.